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The primary outcome was the progression of stenosis in symptomatic
vessels at 6 months. Magnetic resonance findings were used to classify
stenosis into 1 of 5 grades. Progression was defined as worsening of stenosis
by 1 or more grades and regression of stenosis was defined as improvement
of stenosis by 1 or more grades compared to the initial MRA study. Patients
were also assessed with transcranial Doppler examinations.
From February 2000 to July 2003, 135 patients were enrolled in the
trial. Sixty-seven were randomly assigned to cilostazol, and 68 were assigned
to receive placebo. All patients in both groups also received 100 mg of
aspirin daily.
Baseline patient characteristics and the location of intercranial lesions
resulting in symptoms were similar in the two groups. During follow-up,
there were no strokes or transient ischemic attacks, and two participants in
each group had an acute coronary event. There was one unexplained death
in each group. There were 20 dropouts in the cilostazol group (29.9%) and
14 dropouts in the placebo group (20.6%).
Progression of a symptomatic intercranial arterial stenosis occurred in
three (6.7%) of the 45 patients available for follow up in the cilostazol group,
and 15 (28.8%) of the 52 patients available for follow up in the placebo
group. Regression of the intercranial lesion producing symptoms was noted
in 24.4% of the cilostazol group and 15.4% of the placebo group. Overall
progression of an intercranial arterial stenosis associated with symptoms was
less frequent in the cilostazol group than the placebo group (P  .008).
Transcranial Doppler studies also indicated that progression was less fre-
quent in the cilostazol group than in the placebo group (P  .001). The
progression rates of intercranial arterial lesions that were not associated with
symptoms were not different between the two groups (P  .384).
Comment: Although this is a study of intracranial arterial lesions, the
study is of interest in that it documents an effect of cilostazol on an
established arterial stenosis associated with neurologic symptoms. The high
frequency of progression and regression of intracranial lesions noted in this
study suggests that intracranial arterial stenosis may behave much differently
than extracranial carotid stenosis. Nevertheless, the idea that it may be
possible to induce a relative high rate of regression of an arterial lesion by
using pharmacologic manipulation is of considerable interest.
Clinical predictors of transient ischemic attack, stroke, or death within
30 days of carotid angioplasty and stenting
Kastrup A, Groschel K, Schulz JB, et al. Stroke 2005;36:787-91.
Conclusion: Patients with increased age, recent stroke, or hemispheric
transient ischemic attack (TIA) have a higher risk of periprocedural compli-
cation after carotid angioplasty and stenting (CAS) for internal carotid artery
(ICA) stenosis than younger patients or those with asymptomatic ICA
stenosis or retinal TIA.
Summary: It appears combined stroke and death rates after CAS are
higher in symptomatic than asymptomatic patients (Stroke 2003;34:813-
819). The authors sought to identify specific clinical risk factors that may
influence postprocedural complications after CAS. This was a retrospective
review of a prospectively maintained database involving 299 patients (217
men, 82 women, mean age 69  9 years) who underwent CAS for either
asymptomatic (n 129, 43%) or symptomatic (n 170, 57%) ICA stenosis.
Logistic regression analysis was used to determine risk factors associated with
periprocedural (30-day) complications (any TIA, minor stroke, major stroke
or death).
Overall, the 30-day TIA rate was 3.7%. Theminor stroke rate was 5.3%,
and the major stroke rate was 0.7%, with a death rate of 0.7%. Patients
presenting with a minor stroke or hemispheric TIA had a higher risk of
complication than asymptomatic patients (odds ratio [OR] 5.69; 95% con-
fidence interval [CI], 2.03 to 19.57; P  .001). The complication rate in
patients presenting with a retinal TIA and in asymptomatic patients were
similar (OR, 1.42; 95% CI, 0.13 to 9.02; P  .6). Advanced age (OR 1.06;
95%CI 1 to 1.11; P .05), stroke (OR, 8.0; 95%CI, 2.26 to 24.1; P .01),
or hemispheric TIA (OR 4.7; 95% CI, 1.16 to 13.3; P  .004) were all
independent predictors of combined 30-day occurrence of any TIA, stroke,
or death.
Comment:The identification of potential risk factors for CAS is crucial
to proper patient selection for CAS and for patient counseling. This study
helps identify presenting clinical features that may be important in selecting
the patients for CAS. Unfortunately, angiographic features of the carotid
stenoses were not reported. It is likely that a combination of angiographic
and clinical features will ultimately prove most useful in the selection of
patients for CAS.
Vascular access stenosis: comparison of arteriovenous grafts and fistulas
Maya ID, Oser R, Saddekni S, et al. Am J Kid Dis 2004;44:859-65.
Conclusion: Clinical evaluation for stenosis affecting a renal dialysis
access is better for grafts than fistulas. Technical success and patency after
angioplasty for stenoses in fistulas and grafts are essentially equal. After
elective angioplasty, residual stenosis, high postprocedure access pressures,
and female sex predict shorter access patency.
Summary: The authors studied clinical factors predictive of patency of
a renal dialysis access after angioplasty. Relative outcomes of angioplasty of
fistulas versus grafts were compared. During a 2-year period, all patients
referred for a fistulogram for suspected access stenosis were studied. By
protocol, angioplasty was performed for stenoses 50%. Each access was
evaluated for degree of stenosis and number and location of stenotic lesions.
In addition, a ratio of access to systemic systolic pressure was calculated.
Multivariable analysis was used to evaluate clinical factors affecting access
patency after angioplasty, and all procedures were tracked to calculate
intervention-free access survival.
There were 543 fistulograms obtained during the study. Of these, 185
were obtained in fistulas and 358 in grafts. The likelihood of finding a
significant stenosis was significantly higher in grafts than fistulas (69.75% vs
39.4%; P  .001). If a stenosis was present, patients with grafts were more
likely to have two or more stenotic lesions (33.1% vs 12.5%; P .001). After
angioplasty, access to systemic pressure ratios and degree of stenosis were
similar in fistulas and in grafts. In addition, intervention-free survival for
grafts and fistulas was similar (6.2 months vs 7.5 months; P .36). Residual
access stenosis, female sex, and increased postangioplasty access pressure
predicted diminished access survival (P  .006).
Comment: It is clear fistulas require fewer interventions than grafts to
maintain patency. The current data, however, suggests that once angioplasty
is required, subsequent patency is no better for fistulas than for grafts. Once
stenosis develops in a dialysis access, the prognosis for intervention-free
access survival is poor whether the access is synthetic or native.
Randomized controlled trial of prophylactic repair of hemodialysis
arteriovenous graft stenosis
Dember LM, Holmberg EF, Kaufman JS. Kidney Int 2004;66:390-8.
Conclusion: Monitoring dialysis access grafts with static venous pres-
sure monitoring and repairing identified stenoses prophylactically does not
result in prolonged graft survival compared with a strategy of observation
and repair of access only in the case of thrombosis.
Summary:Nonrandomized studies, often using historic controls, have
suggested that prophylactic intervention for identified stenoses in dialysis
access grafts will result in a reduction of overall access-related complications
and access-related costs. Widespread recommendations therefore exist for
access graft monitoring and prophylactic intervention to prevent thrombo-
sis. The authors tested this theory in a prospective randomized trial at their
institution. They compared prophylactic repair of arteriovenous graft steno-
ses with repair at the time of thrombosis.
Dialysis access patients were followed with measurements of static
venous pressure. Static venous pressure is determined by turning off the
dialysis blood pump and using the dialysis machine pressure displays to assess
interaccess venous pressure. The static venous pressure ratio relates the
intergraft pressure normalized to systolic blood pressure. The authors had
previously defined an elevated static venous pressure ratio as0.4. This had
been determined to have the best predictive value for determining access
stenosis (Kidney Int 1995;47:1364-73).
In this study, monthly static venous pressure ratios (SVPR) were
determined. Patients randomized to the intervention group underwent
angiography and angiographic or surgical repair of identified stenosis when
the monthly SVPR was elevated (0.4). Patients randomized to the obser-
vation group only underwent stenosis repair in the case of access thrombosis
or access clinical dysfunction.
The primary end point of the study was access abandonment. Access
abandonment occurred in 14 patients in both the intervention group and
the observation group during the 3.5 years of the study. Time to access
abandonment also did not differ significantly between the treatment groups
(hazard ratio for randomization to intervention, 1.75; 95% confidence
interval [CI], 0.80 to 3.82; P  0.16). The proportion of patients with a
thrombotic event was greater in the observation group (72%) than in the
intervention group (44%) (P  .04). Overall, thrombosis rates were similar
in the two groups, however.
Radiologic or surgical procedures to repair stenosis or restore patency
occurred at rates of 3.1 per patient year and 1.1 per patient year in the
intervention and observation groups respectively (rate ratio, 2.75; 95% CI,
1.93 to 3.96; P  .001). Among patients whose access was abandoned
because of thrombosis, the mean number of procedures before abandon-
ment was 4.7 in the intervention group and 2.7 in the observation group.
Comment: This paper fails to confirm a relationship between access
survival and access monitoring with prophylactic intervention for identified
stenoses. The findings appear to be in direct conflict with results of previ-
ously nonrandomized studies. This study was small and occurred at a single
institution. In addition, the authors’ method of monitoring for access graft
stenosis is not universally utilized. The paper does suggest the need for a
larger, multicentered trial evaluating the merits of prophylactic dialysis
access intervention. Recommendations for prophylactic repair of stenoses
identified in dialysis access grafts may need to be reconsidered.
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